Prothymosin alpha is a small, acidic, essential nuclear protein that plays
a poorly defined role in the proliferation and survival of mammalian cells.
Recently, Vega et al. proposed that exogenous prothymosin alpha can specif
ically increase the phosphorylation of eukaryotic elongation factor 2 (eEF-
2) in extracts of NIH3T3 cells (Vega, F. V., Vidal, A., Hellman, U., Wernst
edt, C., and Dominguez, F. (1998) J. Biol. Chem. 273, 10147-10152). Using s
imilar lysates prepared by four methods (detergent lysis, Dounce homogeniza
tion, digitonin permeabilization, and sonication) and three preparations of
prothymosin alpha, one of which was purified by gentle means (the native p
rotein, and a histidine-tagged recombinant prothymosin alpha expressed eith
er in bacteria or in COS cells), we failed to find a response. A reconstitu
ted system composed of eEF-2, recombinant eEF-2 kinase, calmodulin, and cal
cium was also unaffected by prothymosin alpha. However, unlike our optimize
d buffer, Vega's system included a phosphatase inhibitor, 50 mM fluoride, w
hich when evaluated in our laboratories severely reduced phosphorylation of
all species. Under these conditions, any procedure that decreases the effe
ctive fluoride concentration will relieve the inhibition and appear to acti
vate. Our data do not support a direct relationship between the function of
prothymosin a and the phosphorylation of eEF-2.